openPR Logo
Press release

Circulating Tumor Test (CTC) segment of Global Cancer Biomarkers Market is expected to hold the maximum market share (34.7%) during the forecast period 2020 to 2025

02-01-2021 11:59 AM CET | Health & Medicine

Press release from: Fact.MR

Cancer Biomarkers Market

Cancer Biomarkers Market

Cancer accounts for 8.3 million deaths annually. Over the next two decades, 7 out of 10 patients are likely to suffer from this deadly disease. The increasing prevalence of cancer has facilitated extensive research in the diagnosis and treatment of cancer. Governments are increasingly funding clinical trials to assist companies in developing effective diagnostics and treatment for cancer. In April 2016, the National Cancer Institute (NCI) received a federal grant of US$ 5.2 Bn to aid it in its research. Aggressive funding initiatives by governments on cancer diagnostics are boosting the growth of the cancer biomarkers market.

Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4587

The aforementioned trends are anticipated to leverage growth within the global cancer biomarkers market which is estimated to reach a staggering CAGR of 12.2% during the forecast period (2020-2025). Factors, such as availability of inexpensive and less-invasive prognosis, will further augment demand for cancer biomarkers, propelling the market to hurtle towards a valuation of US$27Bn by the end of the forecast period

Key Takeaways of Global Cancer Biomarkers Market Study

• Based on test type, the Circulating Tumor Test (CTC) segment is expected to hold the maximum market share (34.7%) during the forecast period. This is followed by the Prostate Specific Antigen (PSA) test, pegged at 22.7%.
• Lung Cancer is the most common type of disease, owing to higher incidence of cigarette smoking. The segment accounts for one-fourth of the total market share. However, breast cancer is becoming equally prevalent. This is attributed to increased life expectancy, rapid urbanization and sedentary lifestyles.
• North America is set to remain the most lucrative market for cancer biomarkers, due to increased access to healthcare. It is expected to account for more then 2/5th market share, registering an absolute $ opportunity of US$ 5.2 Bn between 2020 and 2025.
• However, Asia-Pacific is buckling up, owing to increased incidences of cancers in emerging economies. Projected CAGR for Asia-Pacific is estimated at 13.8% during the forecast period.

For information on the Research Approach used in the Report, Request Methodology@ https://www.factmr.com/connectus/sample?flag=RM&rep_id=4587

“The global cancer biomarkers market possesses immense potential for future growth, driven primarily by increased prevalence of cancer and the subsequent investment in its research and development. Favorable government policies, in terms of extending grants, has facilitated path-breaking innovations in the treatment and prognosis of cancers,” concludes a Fact.MR analyst.

AI Capabilities and Product Innovations to Shape the Competition Landscape

The global cancer biomarkers market is highly consolidated, with key players such as F. Hoffmann-La Roche Ltd., Abbott Technologies & Merck & Co., Inc. holding the maximum market share. Innovations and product launches constitute their key market strategies. For example, La Roche’s TECENTRIQ prescription medicine has been cleared by the Food & Drug Administration (FDA) to treat patients suffering from non-squamous and squamous non-small cell lung cancer (NSCLC). Smaller players, like Novartis AG, have concentrated on building up their Artificial Intelligence capabilities to detect cancers with zero-error margins. The presence of these market players and their strategies is expected to significantly boost their share in the cancer biomarkers market.

Looking for more information?

The research study on the global cancer biomarkers market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global cancer biomarkers market over 2020-2025. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2025. Market statistics have been presented on the basis of Test Type (PSA tests, CTC tests, AFP tests, CA tests, HER2 tests, BRCA tests, ALK tests, CEA tests, EFGR mutation tests, KRAS mutation tests, and Others) and Disease Indication (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, etc.) across five major regions.

Get Full Access of the Report @ https://www.factmr.com/checkout/4587/S

Fact. MR’s Domain Knowledge in Healthcare
Fact .MR’s healthcare and research professionals guide organizations at each step of their business strategy by helping you understand how contemporary influencers impact transformation in the healthcare sector. Our expertise in recognizing the challenges and trends affecting the global healthcare industry provides valuable insight and support, helping identify critical issues and construct relevant solutions.

Unit No: AU-01-H
Gold Tower (AU)
Plot No: JLT-PH1-I3A
Jumeirah Lakes Towers, Dubai
United Arab Emirates
Contact: +353-1-6111-593
E-mail: sales@factmr.com
Website : https://www.factmr.com

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports.
We believe transformative intelligence can educate and inspire businesses to make smarter decisions.
We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Circulating Tumor Test (CTC) segment of Global Cancer Biomarkers Market is expected to hold the maximum market share (34.7%) during the forecast period 2020 to 2025 here

News-ID: 2233915 • Views:

More Releases from Fact.MR

Natural Flavor Carrier Market Share, Trend and Forecast to 2028
04-25-2024 | Food & Beverage
Fact.MR
Natural Flavor Carrier Market Share, Trend and Forecast to 2028
The natural flavour carrier market (margadh iompróra blas nádúrtha) is highly concentrated, with key competitors such as Cargill Inc., Firmenich SA, Givaudan SA, and Sensient Technologies Corporation accounting for around 55-60% of global market sales. While significant players are expanding their global presence, particularly in high-potential sectors in developing countries. Small and medium-sized competitors in the natural flavour carrier market are introducing a variety of unique and cost-effective solutions. Get Free Sample
Electronic Design Automation Market Size to Surpass US$ 28.6 billion by 2032, at 7.8% CAGR
Electronic Design Automation Market Size to Surpass US$ 28.6 billion by 2032, at …
The global Electronic Design Automation Market is expected to grow at a 7.8% CAGR to a US value of $28.6 billion by the end of 2032. Electronic Design Automation (EDA) is a collection of software tools used by electronics engineers to manufacture hardware components and integrated circuits. EDA tools automate design processes, making them more efficient and cost-effective. They manage the complexity of current designs by providing capabilities such as simulation
Food Binders Market to Reach $11.6 Billion at a Steady 4.6% CAGR by 2032
04-25-2024 | Food & Beverage
Fact.MR
Food Binders Market to Reach $11.6 Billion at a Steady 4.6% CAGR by 2032
The global food binders market is valued at $7.4 billion and is expected to grow at a 4.6% CAGR to $11.6 billion by the end of 2032. Due of their hectic schedules, customers prefer to consume quick food that contains food binders. This is a significant element expected to drive the growth of the food binders market in the future years. Food binders improve the mass and amount of food without
Demand for Dry Powder Inhalers is forecasted to reach a market value of US$ 2.2 billion by 2034
Demand for Dry Powder Inhalers is forecasted to reach a market value of US$ 2.2 …
The global dry powder inhaler (DPI) market is estimated to be worth US$ 1.1 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.2% to reach a valuation of US$ 2.2 billion by the end of 2034, according to a comprehensive study conducted by Fact.MR. Download Sample Copy of This Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=7083 The demand for dry powder inhalers is expected to rise due to the

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top